Journey Medical (DERM) Non-Current Debt (2020 - 2026)

Journey Medical has reported Non-Current Debt for 7 years, with the latest figure at $22.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 1.0% year-over-year to $22.9 million; the trailing twelve-month figure through Mar 2026 stood at $22.9 million (down 1.0% YoY), and the FY2025 full-year result was $25.3 million, up 1.6% from the prior year.
• Non-Current Debt for Q1 2026 stood at $22.9 million, down from $25.3 million in the prior quarter.
• The five-year high for Non-Current Debt was $25.3 million in Q4 2025, with the low at $9.9 million in Q1 2023.
• Historically, Non-Current Debt has averaged $19.0 million across 5 years, with a median of $19.8 million in 2024.
• Annual changes were most pronounced in 2023 — Non-Current Debt plunged 32.81% — and 2024, when it jumped 70.15%.
• Journey Medical's Non-Current Debt stood at $19.8 million in 2022, then fell by 26.25% to $14.6 million in 2023, then soared by 70.15% to $24.9 million in 2024, then rose by 1.6% to $25.3 million in 2025, then declined by 9.51% to $22.9 million in 2026.
• The last three Non-Current Debt figures came in at $22.9 million (Q1 2026), $25.3 million (Q4 2025), and $19.5 million (Q3 2025), per Business Quant data.